Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2017 | 06-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,771,307 | 2,829,753 | 3,207,672 | 3,589,985 | 2,901,460 |
| Marketable Securities | 427,275 | 288,774 | 208,527 | 117,424 | 118,352 |
| Receivables | 2,917,116 | 3,069,666 | 3,236,431 | 3,156,531 | 3,156,169 |
| Inventories | 1,464,282 | 1,514,448 | 1,470,841 | 1,542,961 | 1,471,437 |
| Other current assets | 251,577 | 180,648 | 163,549 | 165,100 | 154,603 |
| TOTAL | $7,831,557 | $7,883,289 | $8,287,020 | $8,572,001 | $7,802,021 |
| Non-Current Assets | |||||
| PPE Net | 1,644,273 | 1,742,985 | 1,736,169 | 1,790,715 | 1,786,855 |
| Investments And Advances | 693,108 | 565,263 | 680,533 | 836,342 | 775,713 |
| Intangibles | 5,692,194 | 5,745,897 | 5,223,658 | 4,458,863 | 4,271,313 |
| Other Non-Current Assets | 1,200,294 | 1,173,699 | 1,128,860 | 1,131,263 | 1,114,820 |
| TOTAL | $9,229,869 | $9,227,844 | $8,769,220 | $8,217,183 | $7,948,701 |
| Total Assets | $17,061,420 | $17,111,130 | $17,056,240 | $16,789,170 | $15,750,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,126,062 | 1,374,147 | 1,492,553 | 1,510,445 | 1,476,747 |
| Other current liabilities | 1,999,656 | 2,055,420 | 1,970,723 | 1,814,597 | 1,787,227 |
| TOTAL | $3,288,564 | $3,609,450 | $3,680,561 | $3,758,565 | $3,688,083 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 884,061 | 920,619 | 946,864 | 995,543 | 983,029 |
| TOTAL | $1,614,690 | $1,624,824 | $1,290,999 | $1,003,530 | $990,729 |
| Total Liabilities | $4,903,254 | $5,234,265 | $4,971,561 | $4,762,104 | $4,678,821 |
| Shareholders' Equity | |||||
| Common Shares | 927,009 | 927,009 | 947,609 | 1,009,410 | 957,909 |
| Retained earnings | 8,374,968 | 8,013,456 | 8,932,482 | 9,224,015 | 8,312,796 |
| Other shareholders' equity | 1,761,905 | 1,400,793 | 1,432,895 | 523,329 | 596,904 |
| TOTAL | $12,158,160 | $11,876,870 | $12,084,680 | $12,027,080 | $11,071,900 |
| Total Liabilities And Equity | $17,061,414 | $17,111,135 | $17,056,241 | $16,789,184 | $15,750,721 |